Two newly approved solutions, Axtra® XAP
and Syncra® AVI deliver superior technical and
economic performance improvements in poultry feeds
NEW
YORK, June 26, 2024 /PRNewswire/ -- IFF today
announced EU-wide regulatory approval for two of its groundbreaking
feed solutions for poultry. Axtra® XAP – a multi-enzyme
blend and Syncra® AVI – an enzyme-probiotic complex from
Danisco Animal Nutrition & Health, IFF's Health &
Biosciences business unit, are formulated to meet the challenges of
modern poultry production and deliver measurable performance
improvements.
"Obtaining full EU authorization empowers us to unleash the
remarkable potential of these two exceptional in-feed products to
poultry producers across the region," said Jose Luis Ecija Roux, marketing director EMEA,
Danisco Animal Nutrition & Health. "Axtra® XAP and
Syncra® AVI have demonstrated their pivotal role in
advanced feed strategies, and we look forward to helping our
customers in maximizing this unprecedented opportunity."
Axtra® XAP - fuels efficiency and reduces
costs
Axtra® XAP, a high-performance xylanase, amylase and
protease enzyme combination, increases energy efficiency and
improves bird performance in both corn-based and mixed-grain diets.
Through optimized nutrient availability, this unique feed solution
enables greater flexibility in dietary formulations, significantly
reduces feed costs and improving profitability1.
Additionally, Axtra® XAP allows producers to adapt their
operations to meet consumer demands and industry trends, including
free-range production and the use of all-vegetable dietary
ingredients.
Syncra® AVI, a gut health
revolution
Syncra® AVI combines two proven
technologies – enzymes and probiotics – known to optimize gut
health and maximize performance in poultry production. The
synergistic combination of enzymes and probiotics in
Syncra® AVI helps to create a favorable nutribiotic
state that supports flock health, wellness, and productivity.
Nutribiosis is the interplay between nutrition, microbiome, gut and
immune function where they interact in the host.
The EU is the latest region to launch Axtra® XAP and
Syncra® AVI. Both solutions are currently available in
major markets around the world including North America, South
Africa and Asia Pacific.
Learn more about Axtra® XAP, Syncra® AVI and
nutribiosis at https://animalnutrition.iff.com/.
|
1
Internal experimental data
|
About Danisco Animal
Nutrition & Health
Danisco Animal Nutrition & Health, part of IFF is an industry
leader in nutritional health solutions with a comprehensive
portfolio of feed enzymes, betaine, essential oils and probiotics.
Through the lens of nutribiosis, IFF invests in science and
innovation to help producers improve performance, increase
liveability and support welfare in the face of increasing pressure
to reduce or remove antibiotics from production systems. Danisco
Animal Nutrition & Health capabilities are underpinned by the
quality and quantity of our trials, including over 100,000 guts
sampled from over 600 farms, investments in omics technologies and
microbiome research, and collaboration with leading commercial,
governmental and academic partners. For more information, visit
animalnutrition.iff.com
Welcome to IFF
At IFF (NYSE: IFF), an industry leader in food, beverage, health,
biosciences and scent, science and creativity meet to create
essential solutions for a better world – from global icons to
unexpected innovations and experiences. With the beauty of art and
the precision of science, we are an international collective of
thinkers who partners with customers to bring scents, tastes,
experiences, ingredients and solutions for products the world
craves. Together, we will do more good for people and
planet. Learn more at
iff.com, Twitter , Facebook, Instagram,
and LinkedIn.
©2024 International Flavors & Fragrances Inc. (IFF). IFF,
the IFF Logo, and all trademarks and service marks denoted with ™,
SM or ® are owned by IFF or affiliates of IFF
unless otherwise noted. All Rights Reserved.
Contact:
Denisse Gaudin
Marketing Communications Manager
+31615102508
Denisse.gaudin@iff.com
SOURCE IFF